Understand the differences
Transplant pathways
Choose the pathway that matches your enquiry and learn what only a licensed centre can decide.
Pathway navigator
Start with the type of care being considered.
Each page explains the pathway category, what a centre may evaluate, and the questions that protect patients and donors.
01Kidney transplant navigationA practical introduction to living-donor and deceased-donor kidney transplant pathways without promises about eligibility or access.Living-donor and deceased-donor pathways02Liver transplant navigationAn independent overview of living-donor and deceased-donor liver pathways and the questions to take to a licensed centre.Living-donor and deceased-donor pathways03Stem cell and bone marrow transplant navigationA clear distinction between autologous and allogeneic pathways, with a focus on licensed programmes and evidence-based care.Autologous and allogeneic pathways04Corneal transplant navigationAn introduction to corneal tissue pathways, centre evaluation, and the need for regulated tissue handling.Donated tissue pathway05Heart transplant navigationA safety-first explanation of centre evaluation and deceased-donor allocation without promises of access or priority.Deceased-donor allocation pathway06Lung transplant navigationA concise guide to the regulated deceased-donor pathway and questions for specialist centres.Deceased-donor allocation pathway07Pancreas transplant navigationAn overview of specialist assessment and allocation constraints for pancreas and combined kidney-pancreas pathways.Deceased-donor allocation pathway08Other lawful transplant pathwaysA navigation framework for less common pathways that requires specialist, jurisdiction-specific verification.Specialist and jurisdiction-specific pathways
| Pathway | Source | Decision authority | Critical safeguard |
|---|---|---|---|
| Living donor | A medically suitable person | Licensed centre and applicable authorities | Independent donor assessment and voluntary consent |
| Deceased donor | Authorized donation system | National or regional allocation system | Equitable, lawful allocation without purchased priority |
| Tissue and cornea | Regulated tissue donation and banking | Qualified clinical programme | Traceability, processing standards, and follow-up |
| Stem cell | Patient or matched donor, depending on pathway | Specialist transplant programme | Evidence-based indication, matching, and donor safety |
Patient safety
Navigation with firm boundaries
MedTransplant provides independent education and navigation. We do not source organs or donors, influence allocation, or promise clinical acceptance.
Licensed transplant centres make all clinical decisions, and national laws always apply.